Janus Kinase Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GLPG | F | Galapagos NV | 3.13 | |
RIGL | F | Rigel Pharmaceuticals, Inc. | 3.81 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | C | ALPS Medical Breakthroughs ETF | 1.32 | |
BIS | B | ProShares UltraShort Nasdaq Biotechnology | 0.22 | |
IBB | C | iShares Nasdaq Biotechnology Index Fund | 0.17 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.07 | |
IBBQ | C | Invesco Nasdaq Biotechnology ETF | 0.06 |
Compare ETFs
Related Industries:
Biotechnology
- Janus Kinase
Janus kinase (JAK) is a family of intracellular, nonreceptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-STAT pathway. They were initially named "just another kinase" 1 and 2 (since they were just two of a large number of discoveries in a PCR-based screen of kinases), but were ultimately published as "Janus kinase". The name is taken from the two-faced Roman god of beginnings, endings and duality, Janus, because the JAKs possess two near-identical phosphate-transferring domains. One domain exhibits the kinase activity, while the other negatively regulates the kinase activity of the first.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles